Literature DB >> 4043083

Human alpha-L-iduronidase. 2. Catalytic properties.

P R Clements, V Muller, J J Hopwood.   

Abstract

The kinetic parameters of human liver alpha-L-iduronidase were determined with three disaccharide substrates: alpha-L-iduronosyl(1----4)2,5-anhydro-D-[1-3H]mannitol 6-sulphate, alpha-L-iduronosyl(1----4)2,5-anhydro-D-[1-3H]mannitol and alpha-L-iduronosyl(1----3)2,5-anhydro-D-[1-3H]talitol 4-sulphate, derived from the natural substrates heparin and dermatan sulphate and one synthetic, fluorogenic substrate, 4-methylumbelliferyl alpha-L-iduronide. The enzyme activity with all four substrates was optimal at about pH 4.5. The Km values derived using the disaccharide substrates were elevated up to 10-fold with up to a 6.5-fold increase in ionic strength whereas that for the synthetic substrate was only increased by 1.7-fold. The V values for all substrates were unaffected. The inhibitory effect of NaCl, Na2SO4, NaH2PO4 or CuCl2 on enzyme activity was more pronounced with the disaccharide substrates than with the synthetic substrate. The moiety which is most important in binding is the idopyranosyl residue. While the aglycone residue adds to the net affinity for the enzyme, it is the substituent groups of both residues which appear to control catalysis. Specifically the carboxyl moiety of the alpha-L-iduronic acid residue is essential for catalysis while the presence of sulphate on the C4 or C6 position of the aglycone residue has a major influence on catalysis rather than binding. alpha-L-Idosyl(1----4)2,5-anhydro-D-[1-3H]mannitol 6-sulphate did not undergo catalysis and was a potent inhibitor of enzyme activity, whereas beta-glucuronosyl(1----4)2,5-anhydro-D-[1-3H]mannitol 6-sulphate, alpha-L-iduronosyl-2-sulphate(1----4)2,5-anhydro-D-[1-3H]-mannitol 6-sulphate and 4-methylumbelliferyl alpha-L-idoside did not undergo catalysis and were not inhibitory. A model of the catalytic requirements of alpha-L-iduronidase is proposed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4043083     DOI: 10.1111/j.1432-1033.1985.tb09159.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  17 in total

1.  Glucuronate-2-sulphatase activity in cultured human skin fibroblast homogenates.

Authors:  C Freeman; J J Hopwood
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

2.  Diagnosis of Maroteaux-Lamy syndrome by the use of radiolabelled oligosaccharides as substrates for the determination of arylsulphatase B activity.

Authors:  J J Hopwood; H Elliott; V J Muller; G T Saccone
Journal:  Biochem J       Date:  1986-03-15       Impact factor: 3.857

3.  Human liver iduronate-2-sulphatase. Purification, characterization and catalytic properties.

Authors:  J Bielicki; C Freeman; P R Clements; J J Hopwood
Journal:  Biochem J       Date:  1990-10-01       Impact factor: 3.857

4.  Expression, purification and characterization of recombinant human N-acetylgalactosamine-6-sulphatase.

Authors:  J Bielicki; M Fuller; X H Guo; C P Morris; J J Hopewood; D S Anson
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

5.  Human alpha-L-iduronidase. Catalytic properties and an integrated role in the lysosomal degradation of heparan sulphate.

Authors:  C Freeman; J J Hopwood
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

6.  Immunopurification and characterization of human alpha-L-iduronidase with the use of monoclonal antibodies.

Authors:  P R Clements; D A Brooks; P A McCourt; J J Hopwood
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

7.  Human glucosamine-6-sulphatase deficiency. Diagnostic enzymology towards heparin-derived trisaccharide substrates.

Authors:  C Freeman; J J Hopwood
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

8.  Human liver N-acetylglucosamine-6-sulphate sulphatase. Catalytic properties.

Authors:  C Freeman; J J Hopwood
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

9.  Human liver N-acetylgalactosamine 6-sulphatase. Purification and characterization.

Authors:  J Bielicki; J J Hopwood
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

10.  Recombinant alpha-L-iduronidase: characterization of the purified enzyme and correction of mucopolysaccharidosis type I fibroblasts.

Authors:  E G Unger; J Durrant; D S Anson; J J Hopwood
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.